Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

p95HER2 Methionine 611 Carboxy-Terminal Fragment Is Predictive of Trastuzumab Adjuvant Treatment Benefit in the FinHer Trial.

Sperinde J, Huang W, Vehtari A, Chenna A, Kellokumpu-Lehtinen PL, Winslow J, Bono P, Lie YS, Petropoulos CJ, Weidler J, Joensuu H.

Clin Cancer Res. 2018 Jul 1;24(13):3046-3052. doi: 10.1158/1078-0432.CCR-17-3250. Epub 2018 Mar 13.

2.

CCR5 expression is reduced in lymph nodes of HIV type 1-infected women, compared with men, but does not mediate sex-based differences in viral loads.

Meditz AL, Folkvord JM, Lyle NH, Searls K, Lie YS, Coakley EP, McCarter M, Mawhinney S, Connick E.

J Infect Dis. 2014 Mar;209(6):922-30. doi: 10.1093/infdis/jit575. Epub 2013 Oct 31.

3.

Design of a potent D-peptide HIV-1 entry inhibitor with a strong barrier to resistance.

Welch BD, Francis JN, Redman JS, Paul S, Weinstock MT, Reeves JD, Lie YS, Whitby FG, Eckert DM, Hill CP, Root MJ, Kay MS.

J Virol. 2010 Nov;84(21):11235-44. doi: 10.1128/JVI.01339-10. Epub 2010 Aug 18.

4.

A public health model for the molecular surveillance of HIV transmission in San Diego, California.

Smith DM, May SJ, Tweeten S, Drumright L, Pacold ME, Kosakovsky Pond SL, Pesano RL, Lie YS, Richman DD, Frost SD, Woelk CH, Little SJ.

AIDS. 2009 Jan 14;23(2):225-32. doi: 10.1097/QAD.0b013e32831d2a81.

5.

DNA analysis in perpetrator identification of terrorism-related disaster: suicide bombing of the Australian Embassy in Jakarta 2004.

Sudoyo H, Widodo PT, Suryadi H, Lie YS, Safari D, Widjajanto A, Kadarmo DA, Hidayat S, Marzuki S.

Forensic Sci Int Genet. 2008 Jun;2(3):231-7. doi: 10.1016/j.fsigen.2007.12.007. Epub 2008 Feb 12.

PMID:
19083826
6.

Active methamphetamine use is associated with transmitted drug resistance to non-nucleoside reverse transcriptase inhibitors in individuals with HIV infection of unknown duration.

Cachay ER, Moini N, Kosakovsky Pond SL, Pesano R, Lie YS, Aiem H, Butler DM, Letendre S, Mathews WC, Smith DM.

Open AIDS J. 2007;1:5-10. doi: 10.2174/1874613600701010005. Epub 2007 Oct 22.

7.

Development of an HIV-1 reference panel of subtype B envelope clones isolated from the plasma of recently infected individuals.

Schweighardt B, Liu Y, Huang W, Chappey C, Lie YS, Petropoulos CJ, Wrin T.

J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):1-11. Erratum in: J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):528.

PMID:
17514017
8.

Prevalence of primary HIV-1 drug resistance among recently infected adolescents: a multicenter adolescent medicine trials network for HIV/AIDS interventions study.

Viani RM, Peralta L, Aldrovandi G, Kapogiannis BG, Mitchell R, Spector SA, Lie YS, Weidler JM, Bates MP, Liu N, Wilson CM; Adolescent Medicine Trials Network for HIV/AIDS Interventions.

J Infect Dis. 2006 Dec 1;194(11):1505-9. Epub 2006 Oct 20.

PMID:
17083034
10.

Effects of the G190A substitution of HIV reverse transcriptase on phenotypic susceptibility of patient isolates to delavirdine.

Uhlmann EJ, Tebas P, Storch GA, Powderly WG, Lie YS, Whitcomb JM, Hellmann NS, Arens MQ.

J Clin Virol. 2004 Nov;31(3):198-203.

PMID:
15465412
11.

Identification of genes that regulate a left-right asymmetric neuronal migration in Caenorhabditis elegans.

Ch'ng Q, Williams L, Lie YS, Sym M, Whangbo J, Kenyon C.

Genetics. 2003 Aug;164(4):1355-67.

12.

Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors.

Kemper CA, Witt MD, Keiser PH, Dubé MP, Forthal DN, Leibowitz M, Smith DS, Rigby A, Hellmann NS, Lie YS, Leedom J, Richman D, McCutchan JA, Haubrich R; California Collaborative Treatment Group #575 Team.

AIDS. 2001 Mar 30;15(5):609-15.

PMID:
11316998
13.

In vitro translation extracts prepared from Drosophila ovaries and embryos.

Lie YS, Macdonald PM.

Biochem Biophys Res Commun. 2000 Apr 13;270(2):473-81.

PMID:
10753650
14.

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1.

Petropoulos CJ, Parkin NT, Limoli KL, Lie YS, Wrin T, Huang W, Tian H, Smith D, Winslow GA, Capon DJ, Whitcomb JM.

Antimicrob Agents Chemother. 2000 Apr;44(4):920-8.

15.

Smaug, a novel and conserved protein, contributes to repression of nanos mRNA translation in vitro.

Smibert CA, Lie YS, Shillinglaw W, Henzel WJ, Macdonald PM.

RNA. 1999 Dec;5(12):1535-47.

16.

Quantitative competitive reverse transcription-PCR as a method to evaluate retrovirus removal during chromatography procedures.

Lau AS, Lie YS, Norling LA, Sernatinger J, Dinowitz M, Petropoulos CJ, Xu Y.

J Biotechnol. 1999 Oct 8;75(2-3):105-15.

PMID:
10553652
17.
18.

Phenotypic changes in drug susceptibility associated with failure of human immunodeficiency virus type 1 (HIV-1) triple combination therapy.

Parkin NT, Lie YS, Hellmann N, Markowitz M, Bonhoeffer S, Ho DD, Petropoulos CJ.

J Infect Dis. 1999 Sep;180(3):865-70.

PMID:
10438382
19.
20.

Advances in quantitative PCR technology: 5' nuclease assays.

Lie YS, Petropoulos CJ.

Curr Opin Biotechnol. 1998 Feb;9(1):43-8. Review.

PMID:
9503586
21.

Ectopic expression of the maize kn1 gene phenocopies the Hooded mutant of barley.

Williams-Carrier RE, Lie YS, Hake S, Lemaux PG.

Development. 1997 Oct;124(19):3737-45.

22.

Gene transfer and amplification in CHO cells. Efficient methods for maximizing specific productivity and assessment of genetic consequences.

Wurm FM, Johnson A, Ryll T, Köhne C, Scherthan H, Glaab F, Lie YS, Petropoulos CJ, Arathoon WR.

Ann N Y Acad Sci. 1996 May 15;782:70-8. Review. No abstract available.

PMID:
8659926
23.

Chinese hamster ovary cells contain transcriptionally active full-length type C proviruses.

Lie YS, Penuel EM, Low MA, Nguyen TP, Mangahas JO, Anderson KP, Petropoulos CJ.

J Virol. 1994 Dec;68(12):7840-9.

24.

Effects of tumor necrosis factor-alpha treatment on mortality in murine cytomegalovirus-infected mice.

Anderson KP, Lie YS, Low MA, Fennie EH.

Antiviral Res. 1993 Aug;21(4):343-55.

PMID:
8215304
25.

Recent studies on retrovirus-like particles in Chinese hamster ovary cells.

Dinowitz M, Lie YS, Low MA, Lazar R, Fautz C, Potts B, Sernatinger J, Anderson K.

Dev Biol Stand. 1992;76:201-7.

PMID:
1282476
26.

Endogenous origin of defective retroviruslike particles from a recombinant Chinese hamster ovary cell line.

Anderson KP, Low MA, Lie YS, Keller GA, Dinowitz M.

Virology. 1991 Mar;181(1):305-11.

PMID:
1704658
27.

Defective endogenous retrovirus-like sequences and particles of Chinese hamster ovary cells.

Anderson KP, Lie YS, Low MA, Williams SR, Wurm FM, Dinowitz M.

Dev Biol Stand. 1991;75:123-32.

PMID:
1665459
28.

Presence and transcription of intracisternal A-particle-related sequences in CHO cells.

Anderson KP, Lie YS, Low MA, Williams SR, Fennie EH, Nguyen TP, Wurm FM.

J Virol. 1990 May;64(5):2021-32.

29.

Reduced mortality in murine cytomegalovirus infected mice following prophylactic murine interferon-gamma treatment.

Fennie EH, Lie YS, Low MA, Gribling P, Anderson KP.

Antiviral Res. 1988 Nov;10(1-3):27-39.

PMID:
2852918

Supplemental Content

Support Center